By expenditures
| Name | Title | Type |
|---|---|---|
| Karen Apostoli | Executive Director Of Business & Operations | Auditee |
| Scott Duenser | Principal | Auditee |
| Chuck Gusswein | Assurance Manager | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 401505 | 2025 | 2026-05-15 | WIPFLI LLP | $5.59M |
| 357364 | 2024 | 2025-05-28 | Wipfli LLP | $13.19M |
| 303528 | 2023 | 2024-04-15 | Wipfli LLP | $7.61M |
| 55161 | 2022 | 2023-03-29 | Wipfli LLP | $8.63M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 357364 | 2024 | 2025-05-28 | 1138169 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 1138168 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 1138167 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 1138166 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 1138165 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 1138164 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 1138163 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 561727 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 561726 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 561725 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 561724 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 561723 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 561722 | 2024-001 | - | - | L |
| 357364 | 2024 | 2025-05-28 | 561721 | 2024-001 | - | - | L |
| 55161 | 2022 | 2023-03-29 | 635877 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 635876 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 635875 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 635874 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 635873 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 635872 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 635871 | 2022-001 | Significant Deficiency | - | B |
| 55161 | 2022 | 2023-03-29 | 635870 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 635869 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 59435 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 59434 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 59433 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 59432 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 59431 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 59430 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 59429 | 2022-001 | Significant Deficiency | - | B |
| 55161 | 2022 | 2023-03-29 | 59428 | 2022-002 | Significant Deficiency | - | L |
| 55161 | 2022 | 2023-03-29 | 59427 | 2022-002 | Significant Deficiency | - | L |